spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  influenza virus 

 HSMN NewsFeed - 10 Nov 2022
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Sep 2021
Via Nova Therapeutics Announces $20 Million Series A Financing from Aditum Bio to Advance Four Antiviral Programs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Mar 2020
BiondVax's CEO Comments on Impact of COVID-19 Pandemic on the Company's Ongoing Phase 3 Clinical Trial
Biopharmaceuticals
 HSMN NewsFeed - 18 Nov 2019
Enrollment and Randomization of 12,463 Participants Complete in BiondVax's Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine trial
Biopharmaceuticals
 HSMN NewsFeed - 14 Aug 2018
BiondVax Receives Second €6M Tranche Disbursement From the European Investment Bank (EIB)
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Jul 2018
Cepheid Receives FDA Clearance and CLIA Waiver for Xpert(R) Xpress Flu/RSV Test
Diagnostics FDA Product Launch
 HSMN NewsFeed - 28 Jun 2018
Corporate Biotech Executive Mark Germain Joins BiondVax's Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2018
Ansun BioPharma secures $85 million in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 12 Jan 2018
GSK receives FDA approval for expanded indication for FLUARIX(R) QUADRIVALENT (Influenza Vaccine) for persons 6 months and older
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Dec 2017
BiondVax Plans Phase 3 Clinical Trial Following Receipt of Scientific Advice from the European Medicines Agency (EMA)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 Nov 2017
Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board
Devices Personnel
 HSMN NewsFeed - 12 Sep 2017
Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier(R) as a Treatment for Life-Threatening Viruses
Devices FDA
 HSMN NewsFeed - 22 Feb 2017
BD Veritor(TM) System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests
Diagnostics FDA
 HSMN NewsFeed - 2 Jan 2017
BiondVax Receives $US 2.8 Million Investment From Angels High Tech Investments Ltd.
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Nov 2016
GSK Receives FDA Approval for Expanded Indication for Flulaval(R) Quadrivalent (Influenza Vaccine) for Infants 6 Months and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Dec 2014
Sanofi Pasteur Announces FDA Approval of Fluzone(R) Intradermal Quadrivalent (Influenza Vaccine) for Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Aug 2014
FDA Approves Use of AFLURIA(R) Influenza Vaccine with PharmaJet’s Needle-Free Injector
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 28 Jul 2014
Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test for Group A Strep
Diagnostics FDA
 HSMN NewsFeed - 30 Dec 2013
Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test - AmpliVue(R) Group B Strep Assay
Diagnostics FDA
 HSMN NewsFeed - 16 Sep 2013
Quidel Receives Two FDA Clearances for Molecular Diagnostic Tests for Use on Life Technologies QuantStudio(TM) Dx
Diagnostics FDA
 HSMN NewsFeed - 16 Aug 2013
Additional GlaxoSmithKline quadrivalent intramuscular influenza vaccine approved by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Apr 2012
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
Diagnostics FDA
 HSMN NewsFeed - 31 Aug 2011
NexBio's DAS181 (Fludase(R)*) Improves Symptoms in Four Severely Immunocompromised Patients With Life-Threatening Parainfluenza Pneumonitis
Biopharmaceuticals
 HSMN NewsFeed - 23 Aug 2011
IQuum Receives FDA 510(k) Clearance for Liat(TM) Influenza A/B Assay for Influenza Molecular Diagnostics in Approximately 20 Minutes
Diagnostics FDA
 HSMN NewsFeed - 13 Jun 2011
Tetragenetics Announces New CEO and Expands Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Oct 2010
Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
Devices Personnel
 HSMN NewsFeed - 7 Oct 2010
Synthetic Genomics Inc. and J. Craig Venter Institute Form New Company, Synthetic Genomics Vaccines Inc. (SGVI), to Develop Next Generation Vaccines
Biopharmaceuticals
 HSMN NewsFeed - 29 Sep 2010
Quidel Announces FDA Clearance of Its QuickVue(R) RSV 10 Immunoassay Diagnostic Test
Diagnostics FDA
 HSMN NewsFeed - 31 Aug 2010
Quidel Announces FDA Clearance of Its RapidVue(R) hCG Pregnancy Lateral Flow Diagnostic Test
Diagnostics FDA
 HSMN NewsFeed - 4 Jan 2010
Cepheid Receives FDA Emergency Use Authorization (EUA) for First 2009 H1N1 Influenza Assay for CLIA 'Moderate Complexity' Laboratories
Diagnostics FDA
 HSMN NewsFeed - 14 Dec 2009
FDA Grants Emergency Use Authorization for DxNA's GeneSTAT(TM) Integrated PCR-based Influenza Detection System for H1N1 Virus
Diagnostics FDA
 HSMN NewsFeed - 29 Oct 2009
FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Diagnostics FDA
 HSMN NewsFeed - 7 Oct 2009
Baxter Receives European Commission Approval for CELVAPAN H1N1 Pandemic Influenza Vaccine
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Sep 2009
Merck & Co., Inc. Obtains Exclusive U.S. Marketing Rights for AFLURIA(R), Seasonal Influenza Vaccine from CSL Biotherapies
Biopharmaceuticals Distribution
 HSMN NewsFeed - 28 Sep 2009
CSL Biotherapies Reaches Agreement with Merck & Co. on Rights to Market and Distribute Afluria(R) in the U.S.
Biopharmaceuticals Distribution
 HSMN NewsFeed - 24 Jul 2009
FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business
Diagnostics FDA
 HSMN NewsFeed - 5 May 2009
Aethlon Medical Discloses New HIV/AIDS Treatment Data
Devices HIV/AIDS
 HSMN NewsFeed - 11 Mar 2009
Aethlon Medical Announces Significant Viral Load Reduction in Landmark Medical Device Study to Treat HIV/AIDS
Devices HIV/AIDS
 HSMN NewsFeed - 20 Jan 2009
Quidel Corporation Appoints Douglas C. Bryant President & Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 6 Jan 2009
MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 Feb 2008
FDA Grants CLIA Waiver for Quidel's QuickVue(R) RSV Test
Diagnostics FDA
 HSMN NewsFeed - 11 Feb 2008
AVI BioPharma Names Dr. Leslie Hudson as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Feb 2008
MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2008
The Aethlon Hemopurifier(R) Proves Effective in Capturing Bird Flu Virus
Devices
 HSMN NewsFeed - 1 Nov 2007
AVI BioPharma Receives Orphan Drug Designation for AVI-4658 for Treatment of Duchenne Muscular Dystrophy
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Oct 2007
AVI BioPharma Announces Changes to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2007
Use of Quidel QuickVue(R) Rapid Flu Test in Nursing Homes Allows for More Rapid Recognition of Outbreaks and Appropriate Therapies
Diagnostics
 HSMN NewsFeed - 28 Sep 2007
CSL Biotherapies announces FDA marketing approval of Afluria(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Sep 2007
Exclusive Agreement Announced Between Quidel Corporation and Roche Pharma AG
Diagnostics
 HSMN NewsFeed - 19 Sep 2007
FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Aug 2007
Internationally Renowned Artificial Organs Expert Joins HepaLife(TM)
Devices Personnel
 HSMN NewsFeed - 13 Aug 2007
HepaLife(TM) Bioartificial Liver: Analysts Forecast Artificial Liver Market to Surpass $2.7 Billion by 2010
Devices
 HSMN NewsFeed - 17 Jul 2007
Quidel Corporation Announces Exclusive Licenses to Molecular Antiviral Resistance and Detection Technology for Influenza
Diagnostics Licensing
 HSMN NewsFeed - 9 Jul 2007
HepaLife Expands Scientific Team and Continues Development of First-of-its-Kind Artificial Liver Device
Devices Personnel
 HSMN NewsFeed - 26 Jun 2007
Quidel Announces Appointment of Industry Veteran Richard C. Tarbox III as Senior Vice President, Corporate Development Officer
Diagnostics Personnel
 HSMN NewsFeed - 11 Jun 2007
Response Biomedical Files for US FDA 510(k) Market Clearance of Rapid Influenza A+B Test
Diagnostics FDA
 HSMN NewsFeed - 16 May 2007
FDA Advisory Committee Recommends Expanded Use of FluMist(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 May 2007
Amarillo Biosciences Issues Corporate Update on Influenza and Hepatitis C Research and Behcet's Disease and Oral Warts Phase 2 Trials
Biopharmaceuticals
 HSMN NewsFeed - 30 Apr 2007
HepaLife Achieves Major Milestone in Development of Artificial Liver Device
Devices
 HSMN NewsFeed - 17 Apr 2007
FDA Licenses First U.S. Vaccine for Humans Against Avian Influenza
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Mar 2007
LabCorp Adopts Quidel Corporation's QuickVue(R) iFOB Test
Diagnostics
 HSMN NewsFeed - 25 Jan 2007
BioCryst Initiates Phase II Influenza Clinical Trial to Evaluate Peramivir
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2007
FDA Approves MedImmune's Refrigerated Formulation of FluMist(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Dec 2006
Sanofi pasteur Influenza Vaccine Production Tops 170 Million Doses in 2006
Biopharmaceuticals
 HSMN NewsFeed - 5 Oct 2006
GSK's New Flu Vaccine, FluLaval(TM), Provides Americans With a New Option for Fighting the Flu
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Oct 2006
PowderMed to Conduct U.S. Clinical Trial of DNA-Based Annual Influenza Vaccine
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 28 Sep 2006
GSK Grants License for Manufacture of Influenza Treatment Zanamivir
Biopharmaceuticals Licensing
 HSMN NewsFeed - 18 Sep 2006
Quidel Announces FDA 510(k) Clearance of Their New Rapid Test for Detection of Respiratory Syncytial Virus (RSV)
Diagnostics FDA
 HSMN NewsFeed - 14 Aug 2006
MedImmune Replies to FDA's Complete Response Letter for New Formulation of FluMist(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Jul 2006
MedImmune Submits Refrigerator-Stable Formulation of FluMist(R) to FDA for Approval in Younger Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jul 2006
MedImmune Receives Complete Response Letter From FDA for New Formulation of FluMist(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Jul 2006
Cardinal Health Signs Agreement With Roche to Manufacture Tamiflu(R)
Biopharmaceuticals
 HSMN NewsFeed - 6 Jul 2006
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist(R) Vaccine Production
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Jun 2006
BioCryst and Green Cross Enter Agreement to Develop and Commercialize Peramivir in South Korea
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2006
MedImmune Fills Senior Marketing and Sales Post
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2006
Novavax and Esprit Pharma to Co-develop Novel Medicine for Female Sexual Desire Disorder
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 May 2006
Novavax Strengthens Vaccine Development Team with Two New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2006
Novartis Awarded Up to USD220 Million by U.S. Department of Health and Human Services for Development of Cell Culture-Derived Influenza Vaccine
Biopharmaceuticals
 HSMN NewsFeed - 1 May 2006
Phase 3 Study Results of MedImmune's Next-Generation Influenza Vaccine Suggest Better Relative Efficacy Against Matched and Mismatched Strains Compared to the Flu Shot in Young Children
Biopharmaceuticals
 HSMN NewsFeed - 1 May 2006
MedImmune Presents New Data From Pediatric Studies With FluMist(R) At Pediatric Academic Societies Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 3 Apr 2006
MedImmune Adds Substantial Expertise to Commercial Organization With Appointment of Two New Vice Presidents
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2006
AVI BioPharma Reports Successful Inhibition of Multiple Subtypes of Influenza A Using NEUGENE Antisense Therapeutic
Biopharmaceuticals
 HSMN NewsFeed - 30 Mar 2006
GlaxoSmithKline Initiates Human Trial Program With Two H5N1 Pandemic Flu Vaccines
Biopharmaceuticals
 HSMN NewsFeed - 23 Mar 2006
GlaxoSmithKline Submits Biologics License Application for FDA Approval of FluLaval(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Feb 2006
Baxter Receives Contract From National Health Service in United Kingdom to Produce Stockpile of H5N1 Flu Vaccine
Biopharmaceuticals
 HSMN NewsFeed - 25 Jan 2006
Generex Biotechnology Announces Interim Results of Clinical Breast Cancer Trials
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Jan 2006
Roche Opens Full National Distribution for Seasonal Supply of Tamiflu(R)
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 54

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 54 additional stories matching:
influenza virus
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.